Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis?

Purpose: The purpose of this study was to determine the effectiveness of percutaneous transluminal angioplasty (PTA) for treatment of patients with localized stenosis of the infrageniculate popliteal artery and tibio-peroneal trunk (IGPA). Methods: The records of 25 patients undergoing IGPA PTA from...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vascular surgery 1995-10, Vol.22 (4), p.457-465
Main Authors: Treiman, Gerald S., Treiman, Richard L., Ichikawa, Laura, Van Allan, Richard
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Angioplasty, Balloon
Arterial Occlusive Diseases - diagnostic imaging
Arterial Occlusive Diseases - therapy
Female
Follow-Up Studies
Humans
Leg - blood supply
Life Tables
Male
Middle Aged
Popliteal Artery
Radiography
Recurrence
Tibial Arteries
Treatment Outcome
Ultrasonography
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: The purpose of this study was to determine the effectiveness of percutaneous transluminal angioplasty (PTA) for treatment of patients with localized stenosis of the infrageniculate popliteal artery and tibio-peroneal trunk (IGPA). Methods: The records of 25 patients undergoing IGPA PTA from 1983 to 1993 were reviewed. Patients underwent follow-up with clinical examinations, ankle-brachial indexes, Duplex scanning, and arteriography. Demographic variables and cardiovascular risk factors were analyzed and correlated with outcome. Results: Mean follow-up was 44 months. With life-table analysis, clinical and hemodynamic success was 59%, 32%, and 20% at 1, 2, and 3 years, respectively. Average time to recurrence was 17 months. Sixteen patients required a subsequent procedure; two had only repeat PTA, six had repeat PTA followed by arterial bypass, and eight had bypass alone. The mean additional benefit of repeat PTA was 8 months. Eleven of the 14 patients treated with bypass became symptom-free with patent grafts at a mean follow-up of 52 months. No risk factor was statistically significant in predicting success of IGPA PTA Conclusions: IGPA PTA is an expensive temporizing measure with a high rate of recurrence requiring subsequent intervention. The procedure should be restricted to patients with limited life expectancy or contraindications to operation. (J V ASC S URG 1995;22:457-65.)
ISSN:0741-5214
1097-6809
DOI:10.1016/S0741-5214(95)70015-3